Good news! 1st peer-reviewed report of a #coronavirus vaccine study shows promising results in 108 participants:

No serious safety signals
78% in low-dose, 92% in mid-dose, and 100% in high-dose groups developed neutralizing antibodies or a T-cell response to #SARSCoV2.

Based on studies of those who recovered from #COVID19, the spike protein on the surface of the #coronavirus is a key target of the immune system.

This vaccine uses an adenovirus—it cannot replicate but expresses the #coronavirus spike protein.

@TheLancet
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931208-3

This report from a phase 1 study is encouraging, but there’s still a long way to go. That said, we now have MULTIPLE #vaccine shots on goal, and I’m increasingly optimistic that we will eventually have an effective #coronavirus vaccine.

#COVID19
https://twitter.com/drdenagrayson/status/1263902642339790848?s=21 https://twitter.com/drdenagrayson/status/1263902642339790848